Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website

Loading...
Loading...

BRAINTREE, Mass., May 7, 2019 /PRNewswire/ -- Haemonetics Corporation HAE announced that financial results for its fourth quarter and fiscal year ended March 30, 2019 are available on its Investor relations website.

HAE logo April 2016.

The Company is posting the earnings release and results tables that will be referenced on its webcast to its Investor Relations website. 

Direct link to Earnings Release 4Q and FY19:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE4OTc3fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636924163445225608

Direct link to Results Tables 4Q and FY19 That Will Be Referenced on Webcast:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE4OTc2fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636924163445225608

As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on May 7, 2019. The call can be accessed with the following information:

  • U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
  • Conference ID required for access: 4378487
  • A live webcast of the call can be accessed on Haemonetics' investor relations website.
  • Direct link to Conference Call Webcast: https://edge.media-server.com/m6/p/299h3spu

ABOUT HAEMONETICS
Haemonetics HAE is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.  

Investor Contacts         

Media Contact

Gerry Gould, VP-Investor Relations       

Carla Burigatto, VP-Communications

(781) 356-9402   

(781) 348-7263

gerry.gould@haemonetics.com 

carla.burigatto@haemonetics.com 



Olga Vlasova, Sr. Mgr.-Investor Relations


(781) 356 9763


olga.vlasova@haemonetics.com


         

SOURCE Haemonetics Corporation

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsPress ReleasesConference Call Announcements
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...